LOS ANGELES, Jan. 06, 2017 -- Genesis Capital, LLC, a private specialty finance company providing bridge loans to professional developers focused on the rehab and resale of single-family and multi-unit residential real estate, today announced it has achieved record loan originations exceeding $1 billion for 2016.
|
||||||||||
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/0e66b7c1-ea50-438c-801c-69f8fd96ccf2
http://www.globenewswire.com/NewsRoom/AttachmentNg/6ebe276f-2b13-403d-a1b9-810eddb3faf9
“Today Genesis Capital has achieved an important milestone in our industry,” said Robert Wasmund, co-Chief Executive Officer of Genesis Capital. “We have demonstrated our ability to achieve national scale in the residential rehab and renovate sector, which has traditionally been highly fragmented and served by local lenders. It has been exciting to build and prove out our team and model, where we retain the speed, service, and flexibility our customers' businesses require while safely expanding the business in multiple geographies nationwide.”
Funds managed by Genesis Capital provide short-term commercial bridge loans to professional developers active in the rehab, resale, and construction of single family and multi-unit residential real estate. The firm’s borrowers are well capitalized with a proven track record and expertise in the purchase, renovation and sale of single-family and multi-unit assets. The firm has been an active lender since 2007.
“This is a proud day indeed for our incredibly committed group of employees, shareholders, and partners. Although lending origination growth can sometimes be achieved at the expense of credit quality or returns, Genesis has achieved this record growth while also expanding our senior debt financing facilities to over $700 million in available capacity, achieving record returns and operating leverage, and with zero credit losses to date,” said Rayman Mathoda, co-Chief Executive Officer of Genesis Capital.
“Our team is looking forward to continuing to collaborate with our strategic and capital partners to build a world class company focused on this $50+ billion dollar annual industry where we are now able to deliver finance company yields with bank like assets and advance rates in the 70 percent loan to value range,” finished Wasmund and Mathoda.
About The Genesis Family of Companies:
Genesis Capital is a high growth specialty commercial lender focused on residential real estate markets - we provide financing for highly qualified and experienced real estate operators who fix and flip homes and apartment buildings focused on both standard and luxury buyers. Genesis Capital is backed by certain investment funds managed by Oaktree Capital Management, L.P., a leader among global investment managers specializing in alternative investments. Privately held, Genesis Capital is headquartered in Los Angeles, CA. Visit Genesis Capital at www.genesiscapital.com.
Melanie Myburgh 310.694.7507 [email protected]


SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 



